Review Article
A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs
Table 3
Cyclodextrin-based carriers of anticancer drugs.
| Serial number | Drug | Cyclodextrin | Nanocarrier prepared | Outcome | Reference |
| 1 | Doxorubicin | γ-CD | Liposomes | Increased retention in tumor cells | [59] | 2 | Curcumin | HP-γ-CD | Liposomes | Improvement in therapeutic efficacy | [60] | 3 | Methotrexate | β-CD | Niosomes | Increased entrapment efficiency and solubility | [61] | 4 | Camptothecin | β-CD | Nanosponges | Improvement in therapeutic efficacy and reduction in toxic effects | [62] | 5 | Paclitaxel | β-CD | Nanosponges | Prolonged shelf life | [63] | 6 | Doxorubicin | β-cyclodextrin-based star copolymers | Micelles | Enhanced drug release | [64] | 7 | β-lapachone | α-CD | Polymeric millirods | Sustained drug release | [65] | 8 | Camptothecin | Amphiphilic β-CD | Nanoparticles | Prolonged drug release | [66] | 9 | Paclitaxel | Amphiphilic β-CD | Nanoparticles | Increased drug loading capacity | [67] | 10 | Docetaxel | Amphiphilic β-CD | Nanoparticles | Increased solubility and prolonged release | [68] |
|
|